This is the eighth indication approved for Xarelto.
Drug is the only respiratory therapy that can be given at home every 8 weeks.
Blockbuster drug could be key to Humira’s successor.
FDA approved the third oncology drug in the US that targets a key genetic driver of cancer, rather than a specific tumor.
FDA approved yet another indication for pembrolizumab (Keytruda) to treat patients with recurrent, locally advanced or metastatic, squamous cell carcinoma of the esophagus (ESCC).
Drug to treat prostate cancer is expected to produce a major windfall for two pharma makers.
FDA approved the first and only ready-to-use insulin for IV infusion in hospitals and acute care settings.
Approved to treat pediatric patients ages 6 years and older with cystic fibrosis
The first FDA-approved to reduce functional abdominal pain in younger patients with irritable bowel syndrome is now available to medical providers.
Tibsovo (ivosidenib) is an isocitrate dehydrogenase1- inhibitor, originally approved in 2018.